Skip to content
10-Q

Quarterly Report

Accelerated Pharma, Inc.

0001493152-20-006905

← back to feed
Filed
Apr 22, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Apr 22, 2020 4.23M sh
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$225.33K
Operating Cash Flow Q3 2019 · Sep 30, 2018 −$125.97K
Stockholders Equity Q3 2019 · Sep 30, 2019 −$8.51M
Stockholders Equity Q3 2019 · Dec 31, 2018 −$7.85M
Stockholders Equity Q3 2019 · Sep 30, 2018 −$7.85M
Stockholders Equity Q3 2019 · Dec 31, 2017 −$7.43M
Total Liabilities Q3 2019 · Sep 30, 2019 $8.53M
Total Liabilities Q3 2019 · Dec 31, 2018 $7.87M
Current Assets Q3 2019 · Sep 30, 2019 $14.12K
Current Assets Q3 2019 · Dec 31, 2018 $18.87K
Total Assets Q3 2019 · Sep 30, 2019 $14.24K
Total Assets Q3 2019 · Dec 31, 2018 $19.49K
Sga Expense Q3 2019 · Sep 30, 2019 $42.64K
Sga Expense Q3 2019 · Sep 30, 2019 $230.74K
Sga Expense Q3 2019 · Sep 30, 2018 $11.48K
Sga Expense Q3 2019 · Sep 30, 2018 $97.03K
Rd Expense Q3 2019 · Sep 30, 2019 $454
Rd Expense Q3 2019 · Sep 30, 2019 $57.71K
Net Income Q3 2019 · Sep 30, 2019 −$169.35K
Net Income Q3 2019 · Sep 30, 2019 −$663.36K
Net Income Q3 2019 · Sep 30, 2018 −$153.43K
Net Income Q3 2019 · Sep 30, 2018 −$521.11K
Operating Income Q3 2019 · Sep 30, 2019 −$43.1K
Operating Income Q3 2019 · Sep 30, 2019 −$288.46K
Operating Income Q3 2019 · Sep 30, 2018 −$11.48K
Operating Income Q3 2019 · Sep 30, 2018 −$97.03K